DX-1235

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDX-1235
Drug Alias NameVEGF receptor inhibitor (Dyax)VEGFR-2 inhibitor (Dyax)DX-1235
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyax Corp
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A